4-(2-((2-((5-chlorothiophen-2-yl)ethynyl)-5H-purin-6-yl)amino)ethyl)-2-methoxyphenol

ID: ALA5171777

Chembl Id: CHEMBL5171777

PubChem CID: 168270459

Max Phase: Preclinical

Molecular Formula: C20H16ClN5O2S

Molecular Weight: 425.90

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(CCNC2=NC(C#Cc3ccc(Cl)s3)=NC3=NC=NC32)ccc1O

Standard InChI:  InChI=1S/C20H16ClN5O2S/c1-28-15-10-12(2-5-14(15)27)8-9-22-19-18-20(24-11-23-18)26-17(25-19)7-4-13-3-6-16(21)29-13/h2-3,5-6,10-11,18,27H,8-9H2,1H3,(H,22,23,24,25,26)

Standard InChI Key:  MPFMHAAXLGXWPP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5171777

    ---

Associated Targets(Human)

ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.90Molecular Weight (Monoisotopic): 425.0713AlogP: 2.92#Rotatable Bonds: 4
Polar Surface Area: 90.93Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.23CX Basic pKa: 3.80CX LogP: 2.87CX LogD: 2.87
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.74Np Likeness Score: -0.11

References

1. Abel B, Murakami M, Tosh DK, Yu J, Lusvarghi S, Campbell RG, Gao ZG, Jacobson KA, Ambudkar SV..  (2022)  Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2.,  231  [PMID:35152062] [10.1016/j.ejmech.2022.114103]

Source